Hunan Jiudian Pharmaceutical Co Ltd
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Pat… Read more
Hunan Jiudian Pharmaceutical Co Ltd (300705) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.068x
Based on the latest financial reports, Hunan Jiudian Pharmaceutical Co Ltd (300705) has a cash flow conversion efficiency ratio of 0.068x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥180.33 Million) by net assets (CN¥2.66 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hunan Jiudian Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Hunan Jiudian Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hunan Jiudian Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hunan Jiudian Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Dayuan Pumps Ind Co
SHG:603757
|
-0.003x |
|
TES Co. Ltd
KQ:095610
|
0.030x |
|
Ovzon AB
ST:OVZON
|
0.079x |
|
CECEP Techand Ecology&Environment Co Ltd
SHE:300197
|
-0.018x |
|
Cosmo Pharmaceuticals N.V
PINK:CMOPF
|
0.002x |
|
ARGAN EO 2
F:871
|
N/A |
|
Shanxi Blue Flame Holding Co Ltd
SHE:000968
|
0.040x |
|
Gravita India Limited
NSE:GRAVITA
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Hunan Jiudian Pharmaceutical Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Hunan Jiudian Pharmaceutical Co Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.53 Billion | CN¥746.36 Million | 0.295x | +35.18% |
| 2023-12-31 | CN¥1.97 Billion | CN¥431.19 Million | 0.219x | +26.13% |
| 2022-12-31 | CN¥1.55 Billion | CN¥268.99 Million | 0.173x | -0.22% |
| 2021-12-31 | CN¥1.10 Billion | CN¥190.87 Million | 0.174x | -3.27% |
| 2020-12-31 | CN¥835.68 Million | CN¥149.99 Million | 0.179x | +50.70% |
| 2019-12-31 | CN¥761.87 Million | CN¥90.74 Million | 0.119x | +25.36% |
| 2018-12-31 | CN¥718.16 Million | CN¥68.23 Million | 0.095x | -21.99% |
| 2017-12-31 | CN¥660.26 Million | CN¥80.42 Million | 0.122x | -28.61% |
| 2016-12-31 | CN¥323.43 Million | CN¥55.18 Million | 0.171x | +34.88% |
| 2015-12-31 | CN¥254.51 Million | CN¥32.20 Million | 0.126x | -11.82% |
| 2014-12-31 | CN¥209.87 Million | CN¥30.11 Million | 0.143x | -17.81% |
| 2013-12-31 | CN¥175.85 Million | CN¥30.69 Million | 0.175x | -- |